Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition

Summary

Treatment of disinhibition syndrome in participants with Neurodegenerative Disorder.

Timeline

Start

2015-12-01

Primary completion

2017-10-03

Completion

2017-10-03

Outcome

Outcome not reported

Stopped (Enrollment): “The study was terminated prematurely because of difficulty with recruiting.”

Drugs

Indications